Cargando…
Comparative outcomes and risk analysis after cone repair or tricuspid valve replacement for Ebstein's anomaly
OBJECTIVE: Ebstein's anomaly is a rare congenital heart malformation for which surgical and medical management are still controversial. The cone repair has transformed surgical outcomes in many of these patients. We aimed to present our results on the outcomes of patients with Ebstein's an...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328840/ https://www.ncbi.nlm.nih.gov/pubmed/37425446 http://dx.doi.org/10.1016/j.xjon.2023.03.004 |
_version_ | 1785069890961408000 |
---|---|
author | Boyd, Rebekah Kalfa, David Nguyen, Stephanie Setton, Matan Shah, Amee Karamichalis, John Lewis, Matthew Wassercug, Noa Zemer Rosenbaum, Marlon Bacha, Emile |
author_facet | Boyd, Rebekah Kalfa, David Nguyen, Stephanie Setton, Matan Shah, Amee Karamichalis, John Lewis, Matthew Wassercug, Noa Zemer Rosenbaum, Marlon Bacha, Emile |
author_sort | Boyd, Rebekah |
collection | PubMed |
description | OBJECTIVE: Ebstein's anomaly is a rare congenital heart malformation for which surgical and medical management are still controversial. The cone repair has transformed surgical outcomes in many of these patients. We aimed to present our results on the outcomes of patients with Ebstein's anomaly who underwent a cone repair or tricuspid valve replacement. METHODS: A total of 85 patients who underwent a cone repair (mean age, 16.5 years) or tricuspid valve replacement (mean age, 40.8 years) between 2006 and 2021 were included. Univariate, multivariate, and Kaplan–Meier analyses were used to evaluate operative and long-term outcomes. RESULTS: Residual/recurrent greater than mild-to-moderate tricuspid regurgitation at discharge was higher after cone repair compared with tricuspid valve replacement (36% vs 5%; P = .010). However, at last follow-up, the risk of greater than mild-to-moderate tricuspid regurgitation was not different between groups (35% in the cone group vs 37% in the tricuspid valve replacement group; P = .786). The tricuspid valve replacement group had a higher risk of tricuspid valve reoperation (37% vs 9%; P = .005) and tricuspid stenosis (21% vs 0%; P = .002) compared with the cone repair group. Kaplan–Meier freedom from reintervention was 97%, 91%, and 91% at 2, 4, and 6 years after cone repair, respectively, and 84%, 74%, and 68% at 2, 4, and 6 years after tricuspid valve replacement, respectively (P = .0191). At last follow-up, right ventricular function was significantly worse from baseline in the tricuspid valve replacement group (P = .0294). There were no statistical differences between age-stratified cohorts or surgeon volume in the cone repair group. CONCLUSIONS: The cone procedure offers excellent results, with stable tricuspid valve function and low reintervention and death rates at last follow-up. The rate of greater than mild-to-moderate residual tricuspid regurgitation at discharge was higher after cone repair compared with tricuspid valve replacement, but this did not expose the patient to a higher risk of reoperation or death at last follow-up. Tricuspid valve replacement was associated with a significantly higher risk of tricuspid valve reoperation and tricuspid valve stenosis, and worse right ventricular function at last follow-up. |
format | Online Article Text |
id | pubmed-10328840 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-103288402023-07-09 Comparative outcomes and risk analysis after cone repair or tricuspid valve replacement for Ebstein's anomaly Boyd, Rebekah Kalfa, David Nguyen, Stephanie Setton, Matan Shah, Amee Karamichalis, John Lewis, Matthew Wassercug, Noa Zemer Rosenbaum, Marlon Bacha, Emile JTCVS Open Congenital: Ebstein's Anomaly OBJECTIVE: Ebstein's anomaly is a rare congenital heart malformation for which surgical and medical management are still controversial. The cone repair has transformed surgical outcomes in many of these patients. We aimed to present our results on the outcomes of patients with Ebstein's anomaly who underwent a cone repair or tricuspid valve replacement. METHODS: A total of 85 patients who underwent a cone repair (mean age, 16.5 years) or tricuspid valve replacement (mean age, 40.8 years) between 2006 and 2021 were included. Univariate, multivariate, and Kaplan–Meier analyses were used to evaluate operative and long-term outcomes. RESULTS: Residual/recurrent greater than mild-to-moderate tricuspid regurgitation at discharge was higher after cone repair compared with tricuspid valve replacement (36% vs 5%; P = .010). However, at last follow-up, the risk of greater than mild-to-moderate tricuspid regurgitation was not different between groups (35% in the cone group vs 37% in the tricuspid valve replacement group; P = .786). The tricuspid valve replacement group had a higher risk of tricuspid valve reoperation (37% vs 9%; P = .005) and tricuspid stenosis (21% vs 0%; P = .002) compared with the cone repair group. Kaplan–Meier freedom from reintervention was 97%, 91%, and 91% at 2, 4, and 6 years after cone repair, respectively, and 84%, 74%, and 68% at 2, 4, and 6 years after tricuspid valve replacement, respectively (P = .0191). At last follow-up, right ventricular function was significantly worse from baseline in the tricuspid valve replacement group (P = .0294). There were no statistical differences between age-stratified cohorts or surgeon volume in the cone repair group. CONCLUSIONS: The cone procedure offers excellent results, with stable tricuspid valve function and low reintervention and death rates at last follow-up. The rate of greater than mild-to-moderate residual tricuspid regurgitation at discharge was higher after cone repair compared with tricuspid valve replacement, but this did not expose the patient to a higher risk of reoperation or death at last follow-up. Tricuspid valve replacement was associated with a significantly higher risk of tricuspid valve reoperation and tricuspid valve stenosis, and worse right ventricular function at last follow-up. Elsevier 2023-03-17 /pmc/articles/PMC10328840/ /pubmed/37425446 http://dx.doi.org/10.1016/j.xjon.2023.03.004 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Congenital: Ebstein's Anomaly Boyd, Rebekah Kalfa, David Nguyen, Stephanie Setton, Matan Shah, Amee Karamichalis, John Lewis, Matthew Wassercug, Noa Zemer Rosenbaum, Marlon Bacha, Emile Comparative outcomes and risk analysis after cone repair or tricuspid valve replacement for Ebstein's anomaly |
title | Comparative outcomes and risk analysis after cone repair or tricuspid valve replacement for Ebstein's anomaly |
title_full | Comparative outcomes and risk analysis after cone repair or tricuspid valve replacement for Ebstein's anomaly |
title_fullStr | Comparative outcomes and risk analysis after cone repair or tricuspid valve replacement for Ebstein's anomaly |
title_full_unstemmed | Comparative outcomes and risk analysis after cone repair or tricuspid valve replacement for Ebstein's anomaly |
title_short | Comparative outcomes and risk analysis after cone repair or tricuspid valve replacement for Ebstein's anomaly |
title_sort | comparative outcomes and risk analysis after cone repair or tricuspid valve replacement for ebstein's anomaly |
topic | Congenital: Ebstein's Anomaly |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328840/ https://www.ncbi.nlm.nih.gov/pubmed/37425446 http://dx.doi.org/10.1016/j.xjon.2023.03.004 |
work_keys_str_mv | AT boydrebekah comparativeoutcomesandriskanalysisafterconerepairortricuspidvalvereplacementforebsteinsanomaly AT kalfadavid comparativeoutcomesandriskanalysisafterconerepairortricuspidvalvereplacementforebsteinsanomaly AT nguyenstephanie comparativeoutcomesandriskanalysisafterconerepairortricuspidvalvereplacementforebsteinsanomaly AT settonmatan comparativeoutcomesandriskanalysisafterconerepairortricuspidvalvereplacementforebsteinsanomaly AT shahamee comparativeoutcomesandriskanalysisafterconerepairortricuspidvalvereplacementforebsteinsanomaly AT karamichalisjohn comparativeoutcomesandriskanalysisafterconerepairortricuspidvalvereplacementforebsteinsanomaly AT lewismatthew comparativeoutcomesandriskanalysisafterconerepairortricuspidvalvereplacementforebsteinsanomaly AT wassercugnoazemer comparativeoutcomesandriskanalysisafterconerepairortricuspidvalvereplacementforebsteinsanomaly AT rosenbaummarlon comparativeoutcomesandriskanalysisafterconerepairortricuspidvalvereplacementforebsteinsanomaly AT bachaemile comparativeoutcomesandriskanalysisafterconerepairortricuspidvalvereplacementforebsteinsanomaly |